Study to Evaluate the Safety and Immunogenicity of Pandemic Monovalent (H5N1) Influenza Vaccines (Whole Virus Formulation) in Adults 18 and 60 Years of Age
Clinical trial NCT00309647 · COMPLETED
Trial details
- NCT number
- NCT00309647
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-03-29
- Primary completion
- 2006-11-01
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.